Research Analysts’ Recent Ratings Changes for Tabula Rasa HealthCare (TRHC)

Share on StockTwits

A number of firms have modified their ratings and price targets on shares of Tabula Rasa HealthCare (NASDAQ: TRHC) recently:

  • 6/15/2019 – Tabula Rasa HealthCare was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Tabula Rasa HealthCare, Inc. is a provider of patient-specific, data-driven technology and solutions which enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The company’s cloud-based software applications including EireneRx and MedWise Advisor which provide solutions to payers, providers and other healthcare organizations. Tabula Rasa HealthCare, Inc. is based in NJ, United States. “
  • 6/13/2019 – Tabula Rasa HealthCare was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating.
  • 6/11/2019 – Tabula Rasa HealthCare was downgraded by analysts at TheStreet from a “c-” rating to a “d+” rating.
  • 6/8/2019 – Tabula Rasa HealthCare was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Tabula Rasa HealthCare, Inc. is a provider of patient-specific, data-driven technology and solutions which enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The company’s cloud-based software applications including EireneRx and MedWise Advisor which provide solutions to payers, providers and other healthcare organizations. Tabula Rasa HealthCare, Inc. is based in NJ, United States. “
  • 5/30/2019 – Tabula Rasa HealthCare was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Tabula Rasa HealthCare, Inc. is a provider of patient-specific, data-driven technology and solutions which enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The company’s cloud-based software applications including EireneRx and MedWise Advisor which provide solutions to payers, providers and other healthcare organizations. Tabula Rasa HealthCare, Inc. is based in NJ, United States. “
  • 5/23/2019 – Tabula Rasa HealthCare was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Tabula Rasa HealthCare, Inc. is a provider of patient-specific, data-driven technology and solutions which enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The company’s cloud-based software applications including EireneRx and MedWise Advisor which provide solutions to payers, providers and other healthcare organizations. Tabula Rasa HealthCare, Inc. is based in NJ, United States. “
  • 5/15/2019 – Tabula Rasa HealthCare was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Tabula Rasa HealthCare, Inc. is a provider of patient-specific, data-driven technology and solutions which enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The company’s cloud-based software applications including EireneRx and MedWise Advisor which provide solutions to payers, providers and other healthcare organizations. Tabula Rasa HealthCare, Inc. is based in NJ, United States. “
  • 5/13/2019 – Tabula Rasa HealthCare was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating.
  • 5/13/2019 – Tabula Rasa HealthCare had its “buy” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $99.00 price target on the stock. They wrote, “. We reiterate our Overweight rating on TRHC shares and maintain our 12-month price target at $99. Rasa reported 1Q19 results, which appeared to be strong. We note that the company posted strong organic growth of 19%. Adjusted EBITDA was above our estimate and the company reaffirmed its 2019 guidance for revenue and adjusted EBITDA. Our EPS estimates moved lower to reflect the higher interest expense given the 1Q19 convert. While the company has executed in the short term, we suspect that investors are more concerned about the number of acquisitions the company has completed in the last two years and its integration efforts.””
  • 5/9/2019 – Tabula Rasa HealthCare had its price target raised by analysts at Piper Jaffray Companies from $73.00 to $78.00. They now have an “overweight” rating on the stock.
  • 5/8/2019 – Tabula Rasa HealthCare was downgraded by analysts at Zacks Investment Research from a “strong-buy” rating to a “hold” rating. According to Zacks, “Tabula Rasa HealthCare, Inc. is a provider of patient-specific, data-driven technology and solutions which enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The company’s cloud-based software applications including EireneRx and MedWise Advisor which provide solutions to payers, providers and other healthcare organizations. Tabula Rasa HealthCare, Inc. is based in NJ, United States. “
  • 5/7/2019 – Tabula Rasa HealthCare was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating.
  • 5/2/2019 – Tabula Rasa HealthCare was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “strong-buy” rating. They now have a $61.00 price target on the stock. According to Zacks, “Tabula Rasa HealthCare, Inc. is a provider of patient-specific, data-driven technology and solutions which enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The company’s cloud-based software applications including EireneRx and MedWise Advisor which provide solutions to payers, providers and other healthcare organizations. Tabula Rasa HealthCare, Inc. is based in NJ, United States. “
  • 4/30/2019 – Tabula Rasa HealthCare was upgraded by analysts at BidaskClub from a “strong sell” rating to a “sell” rating.
  • 4/23/2019 – Tabula Rasa HealthCare was downgraded by analysts at BidaskClub from a “sell” rating to a “strong sell” rating.

Shares of NASDAQ TRHC opened at $47.53 on Monday. Tabula Rasa HealthCare Inc has a 52 week low of $40.86 and a 52 week high of $91.16. The company has a quick ratio of 1.73, a current ratio of 1.80 and a debt-to-equity ratio of 1.31. The company has a market cap of $1.05 billion, a P/E ratio of 139.79 and a beta of 1.69.

Tabula Rasa HealthCare (NASDAQ:TRHC) last issued its quarterly earnings results on Wednesday, May 8th. The company reported ($0.14) EPS for the quarter, meeting the consensus estimate of ($0.14). Tabula Rasa HealthCare had a positive return on equity of 4.22% and a negative net margin of 18.15%. The firm had revenue of $60.96 million during the quarter, compared to analysts’ expectations of $59.24 million. As a group, equities research analysts anticipate that Tabula Rasa HealthCare Inc will post -0.55 EPS for the current year.

In related news, CEO Calvin H. Knowlton sold 8,000 shares of the stock in a transaction that occurred on Monday, April 8th. The stock was sold at an average price of $54.50, for a total transaction of $436,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Calvin H. Knowlton sold 8,270 shares of the stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $53.68, for a total value of $443,933.60. The disclosure for this sale can be found here. Insiders have sold 40,270 shares of company stock valued at $1,997,454 over the last three months. Insiders own 14.00% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the stock. First Mercantile Trust Co. increased its stake in Tabula Rasa HealthCare by 64.5% in the 1st quarter. First Mercantile Trust Co. now owns 995 shares of the company’s stock worth $56,000 after purchasing an additional 390 shares in the last quarter. Oppenheimer Asset Management Inc. purchased a new position in Tabula Rasa HealthCare in the 4th quarter worth about $135,000. South Dakota Investment Council purchased a new position in Tabula Rasa HealthCare in the 1st quarter worth about $141,000. Belpointe Asset Management LLC purchased a new position in Tabula Rasa HealthCare in the 1st quarter worth about $172,000. Finally, LS Investment Advisors LLC increased its stake in Tabula Rasa HealthCare by 11.2% in the 1st quarter. LS Investment Advisors LLC now owns 3,129 shares of the company’s stock worth $177,000 after purchasing an additional 316 shares in the last quarter. 86.66% of the stock is owned by hedge funds and other institutional investors.

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the field of medication safety in the United States. The company's proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. Its cloud-based software applications include EireneRx, a medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems.

Recommended Story: NASDAQ Stock Market Explained

Receive News & Ratings for Tabula Rasa HealthCare Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare Inc and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Seagate Technology PLC  Expected to Post Earnings of $0.83 Per Share
Seagate Technology PLC Expected to Post Earnings of $0.83 Per Share
$0.41 EPS Expected for Community Healthcare Trust Inc  This Quarter
$0.41 EPS Expected for Community Healthcare Trust Inc This Quarter
Brokerages Expect Milacron Holdings Corp  to Post $0.32 EPS
Brokerages Expect Milacron Holdings Corp to Post $0.32 EPS
Brokerages Expect Quintana Energy Services Inc  to Announce -$0.13 Earnings Per Share
Brokerages Expect Quintana Energy Services Inc to Announce -$0.13 Earnings Per Share
Cypress Semiconductor Co.  Expected to Announce Earnings of $0.24 Per Share
Cypress Semiconductor Co. Expected to Announce Earnings of $0.24 Per Share
Univar Inc  Expected to Announce Earnings of $0.44 Per Share
Univar Inc Expected to Announce Earnings of $0.44 Per Share


© 2006-2019 Ticker Report